Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT03630458 Active, not recruiting - Obesity Clinical Trials

Digestive Properties of Carbohydrate-based Foods

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

Gastric emptying rate, glycemic response, fermentation, and appetitive response are being assessed after consumption of traditional West African carbohydrate-based foods (pearl millet couscous, pearl millet thick porridge) and Western type carbohydrate-based foods (wheat couscous, white rice).

NCT ID: NCT03610958 Active, not recruiting - Obesity Clinical Trials

Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss.

Start date: September 4, 2014
Phase: N/A
Study type: Interventional

Study design to demonstrate the safety and performance of the Epitomee Device

NCT ID: NCT03558685 Active, not recruiting - Obesity Clinical Trials

Weight Loss Diet in Obesity With Metabolic Syndrome

Start date: July 2008
Phase: N/A
Study type: Interventional

Concomitant interventions included lifestyle modification with a personally tailored program of diet as detailed below and physical activity adjusted for age and specific physical limitations, targeting engagement in physical activity of at least 150 minutes/week. Lipid lowering and or blood pressure lowering drugs were prescribed as needed according to guideline-assisted medical practice. Patients were seen by a physician every 3 month. The dietitian had a weekly meeting with the patients for the first three months, every other week during months 4-6, once a month during month 7-9 and every 6 weeks during the last three months of the study.

NCT ID: NCT03555734 Active, not recruiting - Obesity Clinical Trials

Umbrella Review and Updated Systematic Review and Meta-analysis of Pulses/Legumes and Incident Cardiometabolic Diseases

Start date: November 21, 2017
Study type: Observational

The European Association for the Study of Diabetes (EASD) guidelines have not made any specific recommendations regarding dietary pulses. To update the recommendations, the Diabetes and Nutrition Study Group (DNSG) of the EASD commissioned an umbrella review and updated systematic review and meta-analysis using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to summarize the available evidence from prospective cohort studies of the association between dietary pulses/legumes and cardiometabolic disease outcomes (incident cardiovascular diseases, diabetes, hypertension and overweight/obesity).

NCT ID: NCT03554525 Active, not recruiting - Obesity Clinical Trials

Weight Regain After Consumption of Food Supplement and Interventional Diet Program

Start date: April 1, 2017
Phase: Phase 3
Study type: Interventional

Effect of the dietary supplement (FAT-BINDER DAMM) on weight regain after 9 months of control weight program

NCT ID: NCT03552107 Active, not recruiting - Obesity Clinical Trials

Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

Start date: April 11, 2017
Study type: Observational

This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.

NCT ID: NCT03550339 Active, not recruiting - Obesity Clinical Trials

Regulation of Energy Balance and Metabolism - Mechanisms Behind and Beyond Obesity and Weight Loss

Start date: November 2016
Phase: N/A
Study type: Interventional

The study aims to investigate homeostatic and hedonic mechanisms regulating appetite, energy balance and metabolism in obesity and the effects of three distinct obesity treatments on these regulatory mechanisms.

NCT ID: NCT03533738 Active, not recruiting - Obesity Clinical Trials

Effects of Food Sequence on the Glycaemic and Insulinaemic Responses

Start date: October 12, 2017
Phase: N/A
Study type: Interventional

The study hypothesizes that vegetable and protein consumed before a carbohydrate will reduce the glucose response. The vegetables and protein consumed before carbohydrate have different effects on insulin and satiety responses.

NCT ID: NCT03528980 Active, not recruiting - Obesity Clinical Trials

The Impact of Weight Loss Induced by Bariatric Surgery or Nutritional Management on Sexual Function in Men With Severe Obesity

Start date: May 2012
Study type: Observational

Study of the impact of weight loss induced by surgery (interventional group) or optimal nutritional management (control group) on sexual function in men with severe obesity

NCT ID: NCT03520556 Active, not recruiting - Obesity Clinical Trials

Systematic Review and Meta-analysis of the Differential Effects of DHA and EPA on Inflammation

Start date: April 16, 2018
Study type: Observational

According to the World Health Organization, cardiovascular diseases (CVDs) are the number 1 cause of death globally. Systemic and local tissue inflammation is now recognized as a key etiological process leading to CVD. Hence, elevated blood levels of inflammation markers are classified among the well-established risk factors for the development of CVD. Among nutritional strategies to prevent and/or reduce chronic inflammation, long-chain omega 3 PUFA (LCn-3PUFA), notably eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have raised tremendous interest for their purported anti-inflammatory effects. Previous meta-analysis of randomized controlled trials (RCTs) substantiated the anti-inflammatory effect of LCn-3PUFA supplementation as evidenced by significant reductions in plasma concentrations of specific inflammation markers such as C-reactive protein (CRP) and tumor necrosis factor alpha (TNF-alpha). However, it is stressed that almost all of the reported RCTs have used a mix of EPA and DHA in various ratios, as EPA and DHA occur concomitantly and naturally in food (fish oils) and in most dietary supplements. Yet, several recent RCTs have recently been undertaken to test the hypothesis that not all LCn-3PUFAs are equal, at least when it comes to their anti-inflammatory effects. Accordingly, there is increasing interest and evidence for potential distinctive effects of DHA compared to EPA on systemic inflammation, raising the question: Is DHA a more potent anti-inflammatory nutrient than EPA? To formally answer this question, we will conduct a systematic review and meta-analysis of RCTs to assess and compare the individual anti-inflammatory effects of DHA and of EPA. The present work will be a pairwise and network meta-analysis focusing on RCTs comparing the effects of EPA and DHA on surrogate markers of systemic inflammation. The findings generated by these analyses will provide invaluable and timely comparative information on the specific efficacy of DHA and EPA as one of the key nutritional modalities for the treatment of chronic inflammation in high-risk men and women. This is important considering that LCn-3PUFA supplements are increasingly being used by the population and an ever growing market in the dietary supplements' industry.